While IONPs offer significant promise, there are safety concerns that need to be addressed. The biocompatibility and potential toxicity of these nanoparticles need thorough evaluation. Studies have shown that surface modifications can improve the biocompatibility of IONPs, reducing their toxicity and enhancing their circulation time in the bloodstream.
